OpenAI leadership shakeup: Brockman consolidates power as Simo departs ahead of IPO

When OpenAI hired Fidji Simo in May 2025 to become its first CEO of Applications, the appointment did more than add a seasoned consumer-product operator to the roster - it created a structural buffer. Reporting to Altman, Simo absorbed the commercial machinery of the company under a single deputy, letting Altman keep his distance from the day-to-day operational grind. With her full-time departure, that buffer collapses. Instead of naming a successor, OpenAI is dividing her portfolio among President Greg Brockman, CFO Sarah Friar, and Chief Strategy Officer Jason Kwon, with Friar and Kwon now reporting directly to Altman ^[3]. The practical effect is a re-concentration of authority at the very top.

Brockman is the center of gravity in the new arrangement. He now oversees the ChatGPT product business, product roadmaps, engineering priorities, go-to-market, enterprise, and compute, reporting to Altman - what one analysis summarized as 'essentially everything that matters operationally' ^[1]. This is not a caretaker role handed to a fill-in; Brockman is the co-founder who served as OpenAI's founding CTO in 2015 ^[5]and who was a decisive figure during Altman's brief 2023 ouster. Insiders describe him as OpenAI's 'institutional memory and technical conscience' ^[1]. The org chart now tilts back toward the founder-research-product-engineering axis, and the company's reported reorganization around a unified ChatGPT plus Codex/agentic direction fits that tilt.

The timing is not incidental. OpenAI confidentially filed for an IPO in June 2026, then delayed its public debut, and is reportedly weighing a 2027 listing that could target a roughly $1 trillion valuation - up from its most recent private valuation of $852 billion ^[4]. The pressure behind those numbers is stark: the company posted a net loss of roughly $38.5 billion in 2025 on about $13.07 billion in revenue ^[4]. A prospectus that lands in front of public-market investors with that loss profile needs a credible execution story attached to it.

That is the lens through which the reorg reads most clearly. Brockman's mandate is explicitly to drive revenue as the company prepares for a potential listing ^[1], and the move sharpens focus on delivery precisely because public-market investors 'demand predictable execution, transparent governance, and a clear path to profitability' ^[1]. There is a visible internal tension here too: Friar, who inherits part of Simo's portfolio, has reportedly favored delaying the IPO to 2027 over cash-burn concerns ^[4], and a separate report framed the delay as a bid to reach the $1 trillion mark ^[6]. Consolidating operational control under a single founder-operator is the kind of narrative-tightening a company does when it knows its numbers will be scrutinized line by line.

The conventional way to de-risk a leadership transition is to spread responsibility across a deeper bench. OpenAI has done the opposite. By declining to replace Simo and routing her authority upward, the company has concentrated more decision-making in fewer people at the exact moment it is trying to project stability to outside investors. Simo herself remains only as a part-time advisor focused on consumer products, advertising, and health applications ^[3], so the institutional knowledge she built in the applications org largely walks out with her full-time role. TechCrunch framed the vacancy bluntly as 'a real vacuum for him [Altman] to address' ^[2].

This matters because Brockman's own history shows the fragility of a founder-dependent structure. He took a sabbatical through the end of 2024 ^[7]and returned only after roughly three months ^[8]. A structure that funnels product, engineering, go-to-market, and compute through one co-founder works beautifully until that co-founder is unavailable - which has already happened once. The reorg buys focus and coherence, but it trades away the redundancy that a named No. 2 provided.

Public reaction fractured along three distinct lines, and the split is itself revealing. The dominant, sympathetic reading took Simo's health disclosure at face value - she wrote that she had to go on medical leave after 'a severe exacerbation' and revealed she had declined an offer from Mark Zuckerberg of a full year of medical leave ^[3]. Long-covid and chronic-illness communities amplified this framing, foregrounding disease awareness and voicing frustration that even wealthy, well-resourced figures still lack evidence-based treatments, alongside a side debate over whether her condition is long covid or the POTS she was diagnosed with in 2019.

A second, more skeptical camp read the health narrative as convenient cover, pointing to OpenAI quietly pivoting away from initiatives Simo had launched. A third, openly cynical strain tied her exit to a stalled IPO effort and speculated about a cash runway measured in months. Cutting across all three is the Anthropic subtext: commentary noted that ChatGPT consumer growth had cooled and that OpenAI's aggressive pivot toward coding tools put it in a fight where it was seen as losing ground to Anthropic. Whether the reorg is a health-driven reassignment or a strategic retrenchment dressed as one, the community clearly reads Brockman's consolidation as OpenAI circling back to its founder-and-research core to defend its lead.